Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.590
+0.070 (2.78%)
Dec 20, 2024, 4:00 PM EST - Market closed
Boundless Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -61.06 | -49.43 | -45.9 | -25.21 |
| Depreciation & Amortization | 1.04 | 0.96 | 0.94 | 0.68 |
| Loss (Gain) From Sale of Investments | -5.21 | -3.3 | 0.5 | 0.54 |
| Stock-Based Compensation | 6.42 | 3.34 | 2.29 | 1.16 |
| Other Operating Activities | 2.58 | 2.39 | 1.7 | 0.42 |
| Change in Accounts Payable | 3.37 | 1.66 | 1.91 | 1.22 |
| Change in Other Net Operating Assets | -4.1 | -2.46 | -1.05 | -2.06 |
| Operating Cash Flow | -56.96 | -46.86 | -39.6 | -23.25 |
| Capital Expenditures | -2.34 | -0.63 | -1.07 | -2.03 |
| Investment in Securities | -9.77 | -37.63 | 17.2 | -57.25 |
| Investing Cash Flow | -12.11 | -38.26 | 16.13 | -59.29 |
| Issuance of Common Stock | 93.1 | 0.18 | 0.13 | 0.21 |
| Other Financing Activities | -4.44 | -1.96 | - | - |
| Financing Cash Flow | 88.33 | 97.9 | 0.13 | 105.53 |
| Net Cash Flow | 19.25 | 12.78 | -23.34 | 22.99 |
| Free Cash Flow | -59.3 | -47.49 | -40.66 | -25.28 |
| Free Cash Flow Per Share | -5.06 | -39.05 | -37.04 | -29.38 |
| Levered Free Cash Flow | -35.86 | -30.95 | -24.76 | - |
| Unlevered Free Cash Flow | -35.86 | -30.95 | -24.76 | - |
| Change in Net Working Capital | -2.01 | 0.36 | -2.12 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.